Nav: Home

Exploring the mystery of how enzymes work via simulations

May 03, 2016

WASHINGTON, D.C., May 10, 2016 - Enzymes play a crucial role in most biological processes--controlling energy transduction, as well as the transcription and translation of genetic information and signaling. They possess a remarkable capacity to accelerate biochemical reactions by many orders of magnitude compared to their uncatalyzed counterparts.

So there is broad scientific interest in understanding the origin of the catalytic power of enzymes on a molecular level. While many hypotheses have been put forward using both experimental and computational approaches, they must be examined critically.

In The Journal of Chemical Physics, from AIP Publishing, a group of University of Southern California (USC) researchers present a critical review of the dynamical concept--time-dependent coupling between protein conformational motions and chemical reactions--that explores all reasonable definitions of what does and does not qualify as a dynamical effect.

The group's work centers on multiscale computer simulations--for which Arieh Warshel, currently a distinguished professor of chemistry at USC, was awarded the 2013 Nobel Prize in chemistry, along with Michael Levitt and Martin Karplus--for exploring the complex actions of enzymes.

"Our study reviews various proposals governing the catalytic efficiency of enzymes, which requires constructing free energy surfaces associated with the chemical reactions, as well as catalytic landscapes comprising conformational and chemical coordinates," explained Ram Prasad Bora, co-author and a postdoctoral assistant working with Warshel. "It's far from trivial to construct these surfaces using reliable theoretical approaches."

For the group's studies, they tend to construct catalytic free energy surfaces by combining an empirical valence bond (EVB) approach, developed by Warshel and colleagues in the early 1980s to determine reaction free energies of enzymatic reactions, with corresponding uncatalyzed solution reaction surfaces constructed via computational "ab initio quantum chemical calculations." But the "quality of EVB free energy surfaces are improved further--to a desired quantum chemical level--by using a paradynamics approach," Bora added.

Comparing the free energy surfaces--and the various factors contributing to these surfaces--for both enzymatic and solution reactions enabled the group to identify the factors contributing to enzyme catalysis.

"In our studies, it's electrostatic free energy," said Bora. "But, to specifically address dynamical and kinetic isotope effects, we used an autocorrelation function of the energy gap, catalytic landscapes--constructed using a renormalization approach--and a quantum classical patch (QCP) approach to determine that dynamics don't contribute to the catalytic power of enzymes."

The key significance of the group's work? "The catalytic activity of enzymes is fundamental to life, so gaining a solid understanding of the factors controlling and contributing to their activity at the molecular level is crucial," said Bora.

With high-quality scientific data now available for the most interesting and complex biological molecules, "it's essential to re-examine various catalytic proposals--especially electrostatic- and dynamic-based proposals," he continued. "Our review focuses on clarifying the role of logical definitions of different catalytic proposals, as well as on the need for a clear formulation in terms of the assumed potential surface and reaction coordinates."

The group determined, in previous efforts, that electrostatic preorganization actually accounts for the observed catalytic effects of enzymes. Their current work focuses on exploring the alternative dynamical proposal.

In terms of applications, the group's enzyme modeling offers "major medical and fundamental value," said Warshel. "For example, it can provide big improvements in enzyme design and advances in drug resistance. Most significant to me, personally, is that it's a solution to the 100-year-old puzzle of how enzymes really do and don't work."

The scientific field of "computational enzyme designing," in particular, stands to benefit from the group's work. "The idea is to tailor desired enzymes for specific purposes--to be used as catalysts for several chemical and biochemical processes at industrial scales--using computational approaches to create artificial enzymes, which can be tested and further improved in laboratories later," explained Bora.

While the concept of designing enzymes computationally from scratch was initially considered intriguing, the field is evolving slowly. "This is largely because the current enzyme designing protocols don't take the actual enzyme catalytic factors into account," Bora continued. "Our work presents a very detailed discussion of these factors, and clarifies that it isn't useful to try to optimize dynamical effects in enzyme design. Focusing on other factors will enable devising future designing protocols on a scientific basis--which will increase the success rate of computationally designed enzymes."

What's next for the group? "More efforts in enzyme design and drug resistance, as well as studies of complex molecular motors and signal transduction," said Warshel.

The group's critical analysis work will help further the exploration of the catalytic factors controlling enzyme catalysis. "Our clear vision about the enzyme catalytic factors means we can now devise effective artificial enzyme design protocols--purely on a scientific basis--that may fill the gap between rational design and laboratory discovery. This can provide insights into another fundamental issue in biology: What controls the evolution of proteins and enzymes?" noted Bora. "Successful design of enzymes may also help in the control of metabolic pathways."
-end-
The article, "Perspective: Defining and quantifying the role of dynamics in enzyme catalysis," is authored by Arieh Warshel and Ram Prasad Bora. It will appear in the Journal of Chemical Physics May 10, 2016 (DOI: 10.1063/1.4947037). After that date, it can be accessed at http://scitation.aip.org/content/aip/journal/jcp/144/18/10.1063/1.4947037.

ABOUT THE JOURNAL

The Journal of Chemical Physics publishes concise and definitive reports of significant research in the methods and applications of chemical physics. See http://jcp.aip.org.

American Institute of Physics

Related Drug Resistance Articles:

Cause of drug resistance in a drug resistance in intestinal tumors identified
Researchers clarify mechanisms that allow hard-to-treat cancers to develop, and have identified strategies that could lead to new therapies.
Engineered viruses could fight drug resistance
MIT biological engineers can program bacteriophages to kill different strains of E. coli by making mutations in the protein that the viruses use to bind to host cells.
Origin of resistance to lung-cancer drug discovered
Researchers at Kanazawa University report in Nature Communications what causes some lung-cancer patients to have an intrinsic resistance to the drug osimertinib: AXL, a protein belonging to the class of receptor tyrosine kinases.
New drug resistance process found in bacteria
Researchers at the UAB and the UMBC have described a new process capable of generating resistance to synthetic antibacterial drugs within bacterial populations long before their invention and without the existence of any similar substance in nature.
Alzheimer's drug may help battle antibiotic resistance
Dangerous antibiotic-resistant bacteria could soon be targeted with a drug initially developed to treat Alzheimer's disease.
New drug candidates reverse drug resistance in multiple myeloma in preclinical models
A new strategy to enhance the activity of proteasome inhibitors (PIs), which are standard-of-care agents in the treatment of multiple myeloma (MM), was reported by researchers at the Medical University of South Carolina in the journal Leukemia.
Testing cells for cancer drug resistance
Biophysicists at Ruhr-Universit├Ąt Bochum (RUB) have demonstrated that Raman microscopy can be used to detect the resistance of tumour cells to cancer drugs.
Flu virus could evolve resistance to pandemic drug
The influenza virus can evolve resistance to an anti-flu drug currently in development for use in pandemics but only if there are multiple genetic mutations, a study has found.
Drug-resistance of gonorrhoea in the EU: persistent but stable
Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).
Keeping cancer out of breath blocks drug resistance
Chemists have demonstrated a new approach to blocking cancer-drug resistance that they believe could be applied to any type of cancer.
More Drug Resistance News and Drug Resistance Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.